ࡱ> FE g2ɀ\pEvans Gillian (Human Resources) Ba==i8@8X@"1Calibri1Calibri1Calibri1Calibri1Calibri1 Calibri1Calibri14Calibri1 Calibri1Calibri1Calibri1,8Calibri18Calibri18Calibri1>Calibri14Calibri1<Calibri1?Calibri1h8Cambria1Calibri1 Calibri1Arial1Calibri1 Calibri""#,##0;\-""#,##0""#,##0;[Red]\-""#,##0""#,##0.00;\-""#,##0.00#""#,##0.00;[Red]\-""#,##0.005*0_-""* #,##0_-;\-""* #,##0_-;_-""* "-"_-;_-@_-,)'_-* #,##0_-;\-* #,##0_-;_-* "-"_-;_-@_-=,8_-""* #,##0.00_-;\-""* #,##0.00_-;_-""* "-"??_-;_-@_-4+/_-* #,##0.00_-;\-* #,##0.00_-;_-* "-"??_-;_-@_-"Yes";"Yes";"No""True";"True";"False""On";"On";"Off"],[$ -2]\ #,##0.00_);[Red]\([$ -2]\ #,##0.00\)                                                                       ff + ) , *     P  P         `            a>  xx8 <   x x     Q   ||M}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-}  00_)}-}  00_)}-}  00_)}-}  00_)}-}  00_)}-} 00_)}-} 00_)}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef [$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L [$ -}A} 00_)23[$ -}A} 00_)23[$ -}A} 00_)23[$ -}A} 00_)23[$ -}A}  00_)23[$ -}A}! 00_)23 [$ -}A}" 00_)[$ -}A}# 00_)[$ -}A}$ 00_)[$ -}A}% 00_)[$ -}A}& 00_)[$ -}A}' 00_) [$ -}A}( 00_)[$ -}}) }00_)[$ -##0.  }}* 00_)[$ -???##0.??? ??? ???}-}+ 00_)}-}, 00_)}-}- 00_)}-}. 00_)}-}/ 00_)}A}0 a00_)[$ -}A}1 00_)[$ -}A}2 00_)?[$ -}A}3 00_)23[$ -}-}4 00_)}-}5  00_)}}6 ??v00_)̙[$ -##0.  }A}7 }00_)[$ -}A}8 e00_)[$ -}}9 00_)[$ -##0.  }}: ???00_)[$ -???##0.??? ??? ???}-}; 00_)}-}< 00_)}U}= 00_)[$ -##0.}-}> 00_)}d}? 00_)ef[$ef##23??? }d}@ 00_)ef[$ef##23??? }<}A 00_)23[$}<}B 00_)23[$}(}C 00_)}-}D 00_)}<}E 00_)23[$}<}F 00_)23[$}(}G 00_)}(}H 00_)}-}I 00_)}-}J  00_)}-}K 00_)}-}L 00_) 20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L渷 % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  Lմ % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23ږ % 60% - Accent3M( 60% - Accent3 23כ % 60% - Accent4M, 60% - Accent4 23 % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23 % "Accent1AAccent1 O % #Accent2A!Accent2 PM % $Accent3A%Accent3 Y % %Accent4A)Accent4 d % &Accent5A-Accent5 K % 'Accent6A1Accent6  F %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory TextG5Explanatory Text % 0Good;Good  a%1 Heading 1G Heading 1 I}%O2 Heading 2G Heading 2 I}%?3 Heading 3G Heading 3 I}%234 Heading 49 Heading 4 I}%59 Hyperlink  % 6InputuInput ̙ ??v% 7 Linked CellK Linked Cell }% 8NeutralANeutral  e%3Normal % 9Noteb Note   :OutputwOutput  ???%????????? ???;$Percent <Title1Title I}% =TotalMTotal %OO> Warning Text? Warning Text %XTableStyleMedium2PivotStyleLight16`h;Sheet1 fSheet2gSheet3,8Z"CategoryMayJunJulAugSepOct Grand TotalBreast1. Within your health trust how many metastatic breast cancer patients are currently [within the past 6 months] being treated, with any therapy, surgery or palliative care.disodium pamidronate (Aredia)*ibandronic acid or ibandronate (Bondronat),sodium clodronate (Bonefos, Clasteon, Loron)'zoledronic acid or zoledronate (Zometa)denosumab (Xgeva)2. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;Bone Metastases3. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated with adjuvant therapy with the following treatments;4. Within your health trust how many metastatic lung cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.Lung5. Within your health trust how many lung cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;6. Within your health trust how many metastatic renal cell cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.Renal7. Within your health trust how many renal cell carcinoma [RCC] patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;!The Christie NHS Foundation Trust Wilmslow Road ManchesterM20 4BXUnited Kingdom FOI requestsInformation Governance OfficerTel: 0161 446 3000Email: FOI@christie.nhs.ukVThis information is held by The Christie whom you can contact using the details below:*3 )4IC6c9j:ccB g2ɀ >Y,_d  dMbP?_*+%,&ffffff?'ffffff?(?)?M\\WWLXerPS1\Xerox_Follow_You0C 4dXXA4 (210 x 297 mm)DINU"D~SMTJXerox PullPrn PCL6 V4.0.548.8.0RESDLLUniresDLLXrxTrueTypeFontDlOptionTTF_DOWNLOAD_AS_TRUETYPEXrxEdgeToEdgeEDGE_TO_EDGE_OFFColorMode24bppXrxHalftoneXRX_NORMAL_HTXEROX_JOB_SETUP_BEGINCBXEROX_JOB_SETUP_ENDCBXEROX_DOC_BEGINCBXEROX_DOC_SETUP_ENDCBXEROX_PAGE_SETUP_BEGINCBXEROX_PAGE_SETUP_ENDCBXEROX_PAGE_FINISH_BEGINCBXEROX_PAGE_FINISH_ENDCBXEROX_DOC_FINISH_BEGINCBXEROX_DOC_FINISH_ENDCBXEROX_JOB_FINISH_BEGINCBXEROX_JOB_FINISH_ENDCBOrientationPORTRAITCollateONDuplexVERTICALResolutionRes600x600PaperSizeA4D1NRX ?   MSCF,90R)//Uncompressed-Data//uR3)CKZklU>;---: mCv ӇliKDi-P(BĀC>W V A &&D21=nY~{vo=;-+_Q˴[ RV*ՂiDZj4'>kdn @ԎLts0^J4RJZ|Y;g(^HO&n3w`~^S8B.z4to^0ݛKK#kzrY ayB;"ug@ UqgGk#3 1ka}$ OgNR&=0`8Y\\*,:O`Qhvt9E/3-2a19cF'rB I*W_<9=MUDnS5uQ FL \vu6CpJ¡ٵxQnej ث3,qb9Wnm9TBsT[! 6v|yyTP I{A:Ū\0'Y^X ߴAg S9VsF7Cp%` -v'E=%?i;/83_"V~m$/xdtM|ڄHa]m0֊W-qU~Td]N#+KuDw:7{wAW}Kqr ӬS̗sW*Vs3n8)BMȜ ^/¼*F=t >īDr8et:CcbgZN˨doX8G4m )n~+{Y boWxUW;qpve^*w /q$X1>Fj0;$u!j+V4P/kSTڂy1D Fd^\РRG Tdxqt\oesZ w{pk8N@^?iL6.6 +,=n]Qd vw\ٝtHR4[GDv҂äNyi{م3iy!-]sH gWCZ5  , , , , , , , , , , , , ,,,,,,,,,,,,,,, C ? @ @ @ @ @ @ @ A0BA@B<@B>@BF@BD@BH@B`l@ C C C C C C ? @ @ @ @ @ @ @ D E0 F?F?F@F@F@F?F(@ D D C C C C C C! K II K II K II K II K II L II K II K II J II:PpBzL  ,!,#,$,&,',(,),*,+,-,.,0 ,2 ,3 ,5 ,6 ,7 ,8 ,9 ,: ,< ,= , JII !C !II #? #@ #@ #@ #@ #@ #@ #@ $A0$BG@BE@BH@B:@B?@BC@B m@ &C 'C (C )C *C +C -? -@ -@ -@ -@ -@ -@ -@ .G0.H@H@H@H @H@H@HA@ 0C 2? 2@ 2@ 2@ 2@ 2@ 2@ 2@ 3A03B(@B"@B"@B@B&@B(@BM@ 5C 6C 7C 8C 9C :C <? <@ <@ <@ <@ <@ <@ <@<D =A0=B?B?BBBB@B@=D2pBpBpBz>@BB&&&yK yK Nmailto:FOI@christie.nhs.ukyX;H,]ą'cggD g2ɀ g  dMbP?_*+%,&ffffff?'ffffff?(?)?",333333?333333?ɜ&<3U>@ggD g2ɀ h  dMbP?_*+%,&ffffff?'ffffff?(?)?",333333?333333?&<3U>@ggD Oh+'0@Hd Griffiths Pamela Evans Gillian (Human Resources)Microsoft Excel@6@Apۨ՜.+,D՜.+,L PX  4Wrightington, Wigan and Leigh NHS Foundation Trust Sheet1Sheet2Sheet3  Worksheets 8@ _PID_HLINKSApemailto:FOI@christie.nhs.uk  !"#$%&'()*+,-./012346789:;<>?@ABCDRoot Entry FWorkbookiSummaryInformation(5DocumentSummaryInformation8=